World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02235493
Date of registration: 05/09/2014
Prospective Registration: No
Primary sponsor: Alexion Pharmaceuticals
Public title: Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09
Scientific title: A Single-Center, Non-interventional Substudy of ALX-HPP-502 to Assess Functional Natural History Data of Patients With Juvenile Historical Controls in ENB-006-09
Date of first enrolment: August 2014
Target sample size: 6
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02235493
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Documented informed consent/assent prior to video collection and data abstraction.

- Documented informed consent/assent in Study ALX-HPP-502.

- Patients with juvenile-onset HPP and was selected as a historical-control for Study
ENB-006-09.

- Patients with at least 2 videos of basic mobility that were recorded at 2 different
clinic visits when the patient was =5 to =15 ye

Exclusion Criteria:

- There are no exclusion criteria for this study



Age minimum: 5 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Hypophosphatasia
Bone Disease
Intervention(s)
Biological: Retrospective Case Only
Primary Outcome(s)
Modified Performance-Oriented Mobility Assessment-Gait Subtest (MPOMA-G) - Change From Baseline to Last Overall [Time Frame: The earliest available MPOMA-G score that was assessed within the period of patients' aged 5 to 15 years, inclusive.]
Secondary Outcome(s)
Performance-Oriented Mobility Assessment-Gait Subtest (POMA-G) - Change From Baseline to Last Overall [Time Frame: The earliest available MPOMA-G score that was assessed within the period of patients' aged 5 to 15 years, inclusive.]
Secondary ID(s)
ALX-HPP-502s
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 28/09/2015
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT02235493
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history